baber/WOPTO huggingface dataset:
Patent CA-2260258-A1 (CA)
Title: Wound healing accelerators
Inventor: YONETA TOMOYUKI
IPC: A61K31/4172
Filed: 1997-06-25
Abstract: Accelerators for healing wounds accompanied by skin defects which contain as the active ingredient zinc L-carnosinate or L-carnosin/zinc complex. These drugs are excellent in the effects of acceleratin g the healing of wounds such as defective wounds, burns, frostbites and bedsores.
Patent CA-2260299-A1 (CA)
Title: Article dispensing apparatus
Inventor: MUELLER MICHAEL A
IPC: G07F11/42
Filed: 1999-01-25
Abstract: An apparatus for dispensing unpackaged articles includes a guide shaft to carry the articles, a pushing element that advances the plurality of articles along the guide shaft, and a feed screw engagable with the pushing element and driven by a motor. While the articles to be dispensed are moved collectively as a group, the apparatus provides for the controlled dispensing of individual articles. A sensor is provided to identify when an article has been dispensed and to subsequently stop movement of the plurality of articles. Also, an iris including a yieldable opening sized to allow passage therethrough of an article in a staggered manner is provided to facilitate the individual dispensing of articles and to prevent the inadvertent dispensing of articles.
Patent CA-2260501-A1 (CA)
Title: Arrangement in a network structure
Inventor: OLTEDAL EINAR
IPC: H04M3/42
Filed: 1999-01-28
Abstract: The present invention relates to an arrangement in a network structure, especially an IN (Intelligent Network) structure, comprising ADSI (Analogue Display Services Interface) and associated servers communicating with ADSI capable devices, and for the purpose of improving the user interface in connection with such devices, it is according to the present invention suggested that said ASDI servers are adapted to a system for use as IPs (Intelligent Peripherals) in combination with especially ADSI compliant telephones.
Patent CA-2261461-A1 (CA)
Title: Control console and seating arrangement for motorized watercraft
Inventor: KOIZUMI MARVIN
IPC: B63B29/04
Filed: 1999-02-11
Abstract: A novel rotatable seating arrangement for a motorized watercraft has an integral console with instrumentation and watercraft controls thereon to allow the watercraft's operator to control operation of the watercraft from one location, and to perform other functions, such as fishing, without obstruction from the console and from the same position while retaining the ability to control the watercraft. The seating arrangement has a generally upright pedestal fixed to the watercraft's deck and a platform pivotally mounted atop the pedestal. A seat is fixed to the platform for supporting the operator in an upright seated position, the seat and platform being rotatable about a longitudinal axis of said pedestal to make available to the operator a 360 degree viewing area while operating the watercraft from the seated position. A locking system on the platform engages the pedestal for controlling rotation of the seat. A control console for carrying watercraft instrumentation and controls is fixed to the rotateable platform adjacent the seat within reach and view of the operator to allow operation of the watercraft while seated. The control console includes a left side portion to the left side of a seated operator and a right side portion to the right side of a seated operator, which side portions are located just above the height of the base of the seat to avoid interfering with the seated operator's use of hand-held equipment. An engine throttle and shift controller is located on the left or right side portion, and a steering controller is located on the other side portion, to allow the operator to operate the watercraft in the seated position regardless of the rotation of the seat.
Patent CA-2263167-A1 (CA)
Title: Ether muscarinic antagonists
Inventor: DUGAR SUNDEEP
IPC: C07D211/46
Filed: 1997-08-13
Abstract: 1,4 Di-substituted piperidine muscarinic antagonists of formula (I) or an isomer, pharmaceutically acceptable salt, ester or solvate thereof, wherein X  is a bond, -O-, -S-, -SO-, -SO2-, -CO-, -C(OR7)2-, -CH2-O-, -O-CH2-, -CH~CH--CH2-, -CH(C1-C6 alkyl)-, -C(C1-C6 alkyl)2-, -CONRI17- -NR17CO-, -O-C(O)NR17-, -NR17C(O)-O-, -SO2NR17- or-NR17SO2-; R is cycloalkyl, optionally substituted phenyl or optionally substituted pyridyl; R2 is H, alkyl, optionally substituted cycloalkyl, cycloalkenyl, t-butoxycarbonyl or optionally substituted piperidinyl; and the remaining variables are as defined in the specification, are disclosed. Compounds of formula (I) are useful for treating cognitive disorders such as Alzheimer's disease. Also disclosed are pharmaceutical compositions, methods of preparation and combinations of compounds of formula (I) with ACh'ase inhibitors.
Patent CA-2265421-A1 (CA)
Title: Furnace vent and intake terminal and blockage safety shut down system
Inventor: DOBRE DAN C
IPC: F23M11/00
Filed: 1999-03-12
Abstract: A horizontal combined air intake and combustion gas vent terminal assembly is provided having improved wind pressure response and anti-recirculation characteristics. The terminal has a vent conduit disposed inside an air intake conduit. A scoop assembly is provided at the intake conduit inlet to increase the intake air pressure at the inlet. The vent conduit is nozzle-like to throttle combustion gases, thereby accelerating the gases and permitting the terminal to project the gases away from the intake conduit terminal. Vent conduit is disposed asymmetrically with intake conduit to further discourage mixing of intake air and combustion gases. The terminal may also be provided with a static pressure measuring means to provide an intrinsic safety shut down system within the terminal in case of blockage of the intake or vent by snow, ice or other debris.
Patent CA-2268389-A1 (CA)
Inventor: HUBBE PASCAL
IPC: H04W88/02
Filed: 1999-04-20
Abstract: Procédé d'affichage d'une séquence d'images sur un moyen de visualisation (V) associé à un équipement mobile (ME) de radiocommunication coopérant avec un module d'identification d'abonné (SIM), comportant les étapes ordonnées suivantes: ~ émission par ledit module d'identification d'abonné (SIM) d'une commande (C) d'affichage de séquence d'images, à destination dudit équipement mobile (ME), ~ exécution par ledit équipement mobile (ME) de ladite commande (C) sur ledit moyen de visualisation (V).
Patent CA-2270571-A1 (CA)
Title: Composite article with adherent cvd diamond coating and method of making
Inventor: OLSON JAMES M
IPC: C23C16/26
Filed: 1999-04-30
Abstract: A process for coating a tungsten carbide base material substrate with CVD diamond film includes carburization and gas-assisted vaporization of cobalt from the surface with simultaneous recrystallization of surface grains of tungsten carbide to change their stoichiometry for improved adherence. Also disclosed is a WC-Co cutting tool having a relatively fine WC grain size and being coated with adherent CVD diamond.
Patent CA-2271313-A1 (CA)
Inventor: SOEDERBAERG ANDERS
IPC: H01L29/73
Filed: 1997-11-13
Abstract: The invention relates to a semiconductor device and a method in this device, wherein the semiconductor device operates completely or partly in lateral extension. The semiconductor device comprises at least two high-voltage lateral bipolar transistors with at least two mutually opposite emitter/base regions, which are placed at the surface of the epi-taxial layer at a mutual distance such that an intermediate common collector region is formed. The common collector region can be completely depleted when the device has a voltage applied and by using a lateral depletion of said collector region, the voltage durability of the semiconductor device can be determined lithographically by the distance between the doped regions comprised in the device. Furthermore, undesired parasitic components, which are dependent on the quality of the active layer of the device, resistivity and substrate potential, can be eliminated or suppressed.
Patent CA-2273848-A1 (CA)
Title: Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
Inventor: ZUMLA ALIMUDDIN ISMAIL
IPC: A61K35/74
Filed: 1997-12-17
Abstract: Antigenic and/or immunogenic material derived from Mycobacterium vaccae is used to down-regulate Th2 activity of the immune system without up-regulation of Th1 activity. Disorders such as Chronic Fatigue Syndrome, Gulf War Syndrome and Total Allergy Syndrome are treated. The material preferably comprises dead M. vaccae cells in a composition which does not include a non-M. vaccae antigen, immunogen or allergen.
Patent CA-2274379-A1 (CA)
Title: Method for increasing the electrical resistivity of hindered polyol ester refrigerant lubricants
Inventor: SCHNUR NICHOLAS E
IPC: C07C69/28
Filed: 1995-05-01
Abstract: The electrical resistivity of hindered polyol ester lubricants can be raised to very high levels by treating the lubricants with activated alumina, preferably after the acid values of the lubricants treated have already been reduced to low levels by conventional refining with alkali or other acid scavengers.
Patent CA-2275645-A1 (CA)
Inventor: STENSTROEM HELGE
IPC: H03M1/40
Filed: 1997-12-05
Abstract: Cyclic A/D-conversion of an analog input signal is performed according to a new and inventive recursive algorithm which generates a Gray coded digital output signal. In cyclic A/D-conversion, the output bits are generated cyclically, one by one. According to the inventive Gray coding algorithm, the analog input signal is cyclically subjected to a sample and hold operation, selectively, depending on the previously generated output bit, to a signal inversion, to an amplification by two, and to an addition of a predetermined reference signal. In a cyclic A/D-converter architecture based on the recursive Gray coding algorithm according to the invention, the accumulation of offset errors will generally be very low. Furthermore, the fact that the signal inversion is digitally controlled enables high precision implementations which further improve the performance of the cyclic A/D-converter according to the invention.
Patent CA-2275791-A1 (CA)
Title: Apparatus and method for wrapping compressible articles with a web-like wrapping material
Inventor: KRAMPS JAN
IPC: B65B11/10
Filed: 1999-06-21
Abstract: The apparatus for wrapping compressible box-like articles (10) such as a stock of newspapers or magazines, with a web-like wrapping material (12). The apparatus has three serially arranged belt conveyors (16, 18, 20), and the second belt conveyor (18) is in the form of a bearing table (24) which can be rotated about a vertical axis (26). The bearing table mounts two pressure-exerting members (30, 32). The article (10') which is to be wrapped is introduced in a compressed state, by the first belt conveyor (16), into a wrap-around channel (42) which is formed by the table (24) and one of the pressure-exerting members (30), and the wrapping material (70) is positioned around the article in the form of a U. At the same time, the article (10), which has been previously wrapped in this way, is transferred to the third belt conveyor (20). A  guide arrangement (62) for the wrapping material is then moved in a downward direction forming a loop of the material which is composed of a first end section (76) and a parallel second end section (78) which is guided along the trailing side (82) of the article. The loop of the material (70) is then severed at the base of the loop and the bearing table (24) is rotated in order that, as the article (10') is transferred to the third belt conveyor (20), the end section (78) is positioned against the article (10') to complete the wrapping. The first end section (76) is positioned to be engaged by the next article as it is advanced onto the table (24).
Patent CA-2275953-A1 (CA)
Inventor: WALLERAND FLORENCE
IPC: A23L1/00
Filed: 1997-12-10
Abstract: The invention concerns a method for coating cheese which consists in applying directly on the cheese to be coated successively at least a layer of a hydrophobic edible composition, and at least a layer of a hydrophilic edible composition, an emulsifying agent being present in the hydrophobic layer adjacent to a hydrophilic layer, the hydrophilic layer adjacent to a hydrophobic layer or to the interface between a hydrophobic layer and a hydrophilic layer.
Patent CA-2277500-A1 (CA)
Inventor: SHORE T MICHAEL
IPC: B21B47/00
Filed: 1999-07-12
Abstract: In a rolling mill where hot rolled steel rod is directed along a delivery path to a laying head which forms the rod into a continuous series of rings, and the rings are deposited in an overlapping pattern on a conveyor for transport along a continuation of the delivery path to a reforming station, the improvement comprising mounting the laying head on an underlying support structure in a manner accommodating a horizontal shifting of the direction of deposit of rings on the conveyor. Clamps releaseably secure the laying head on the support structure at any selected position of adjustment.
Patent CA-2278539-A1 (CA)
Title: Bone regeneration in osteoporosis using human bone marrow mesenchymal cells
Inventor: BRUDER SCOTT P
IPC: A61K35/12
Filed: 1998-01-22
Abstract: The method of osteoporosis treatment and infusion compositions of the invention increase the number of the patient's own progenitor cells (hMSCs) and the reservoir of available bone-forming osteoblasts. They can be used to generate cortical and cancellous bone which has been lost as a result of post-menopausal osteoporosis, male idiopathic osteoporosis, congenital osteoporosis and other bone resorption diseases. Most cases of osteoporosis can be treated with a metered intravenous infusion of the composition of the invention over the course of 15-30 minutes, using customary cell reinfusion therapy techniques.
Patent CA-2279463-A1 (CA)
Title: Method for operating a cryogenic rectification column
Inventor: BILLINGHAM JOHN FREDRIC
IPC: F25J3/04
Filed: 1999-07-30
Abstract: A method for operating a cryogenic rectification column for the separation of the components of air by cryogenic rectification, whereby the column may be operated above its design capacity without encountering flooding, by passing vapor upward through the column at a flowrate which generates a pressure drop within the column of at least 0.7 inches of water per foot of packing height through a height of defined structured packing sheets having a different structure in their upper and lower portions.
Patent CA-2283901-A1 (CA)
Title: Compositions pharmaceutiques
Inventor: WOO JONG SOO
IPC: A61K38/13
Filed: 1998-03-12
Abstract: La présente invention concerne une préparation pour capsules molles à base de cyclosporine. Cette préparation comprend une composition contenant de la cyclosporine comme substance active; un polyéthylèneglycol de composant hydrophile ou un carbonate de propylène de composant non hydrophile, ou leur mélange, un composant ou un mélange de deux ou plusieurs composants sélectionnés dans le groupe se composant d'un composé estérifié d'acide gras et d'alcool primaire, de triglycéride d'acide gras à chaîne moyenne et de monoglycéride d'acide gras comme composant d'huile ainsi qu'un tensio-actif dont la valeur de rapport hydrophile-lipophile se situe entre 8 et 17.
Patent CA-2287192-A1 (CA)
Inventor: GATTAMORTA RUBEN D
IPC: G09F21/02
Filed: 1998-04-24
Abstract: L'invention porte sur un ensemble visière (10) décoratif qui comprend des premier et second panneaux (20 et 22) généralement plans et un ensemble de fixation conçu pour coupler de manière sélective et avec précision le premier panneau (10) au second panneau (22). Cet ensemble de fixation comprend lui-même un élément de scellement périphérique (27) conçu pour former une chambre primaire (25) entre les premier et second panneaux (20 et 22), cet élément de scellement étant pratiquement imperméable au fluide de sorte que la chambre primaire (25) puisse contenir une quantité de fluide dans laquelle il est sélectivement introduit et retiré. L'ensemble de scellement comprend également une pluralité d'éléments de scellement internes (32, 34 et 35) qui raccorde le premier panneau (20) au second panneau (22) de sorte que, lors du gonflement de la chambre primaire (25), une force soit transmise et crée une région avant (40) formant de l'ombre et une région arrière (50) de fixation.
Patent CA-2287255-A1 (CA)
Inventor: LAN NANCY C
IPC: C07D317/50
Filed: 1998-04-22
Abstract: La présente invention concerne des semicarbazones et thiosemicarbazones carbocycliques et hétérocycliques substitués représentés par la formule générale (I) ou l'un de ses sels pharmaceutiquement admis, voire certains promédocaments qui en sont issus. En l'occurrence, Y est oxygène, R¿1?, R¿21?, R¿22? et R¿23? sont indépendamment hydrogène, alkyle, cycloalkyle, alcényle, alkynyle, haloalkyle, aryle, aminoalkyle, hydroxyalkyle, alcoxyalkyle ou carboxyalkyle. Mais R¿22? et R¿23? peuvent ensemble avec le N, former un hétérocycle. A¿1? et A¿2? sont indépendamment aryle, hétéroaryle, carbocycle saturé ou partiellement insaturé, ou encore hétérocycle saturé ou partiellement insaturé, l'un quelconque d'entre eux pouvant être éventuellement substitué. X est fonctionnalisation one ou O, S, NR¿24?, CR¿25?R¿26?, C(O), NR¿24?C(O), C(O)NR¿24?, SO, SO¿2? ou une liaison covalente. R¿24?, R¿25? et R¿26? sont indépendamment hydrogène, alkyle, cycloalkyle, alcényle, alkynyle, haloalkyle, aryle, aminoalkyle, hydroxyalkyle, alcoxyalkyle ou carboxyalkyle. L'invention concerne également l'utilisation de semicarbazones et thiosemicarbazones carbocycliques et hétérocycliques substitués, pour le traitement des lésions neurales faisant suite à une ischémie globale et focale, pour le traitement ou la prévention d'états neurodégénérescents tels que la sclérose amyiotrophique latérale (ALS), pour le traitement et la prévention des affections otoneurotoxiques et ophtalmologiques liées à une toxicité par les glutamates et pour le traitement, la prévention ou le soulagement des douleurs, comme anticonvulsifs, et comme anti-maniaco-dépresseurs, comme anesthésiques locaux, comme antiarythmiques et pour le traitement ou la prévention de la neuropathie motrice amyotrophique et de l'incontinence urinaire.
Patent CA-2288048-A1 (CA)
Title: Ameliorations apportees a des generateurs de gaz
Inventor: INCE ANDREW TIMOTHY
IPC: C25B9/19
Filed: 1998-04-24
Abstract: L'invention concerne un générateur de gaz comportant une couche d'un premier matériau pourvue d'une couche d'un deuxième matériau sur une face et d'une couche d'un troisième matériau sur la face opposée. L'application d'un potentiel externe entraîne la circulation du gaz d'un côté du générateur vers l'autre côté en raison des propriétés des matériaux utilisés. L'utilisation d'un matériau électrolytique comme premier matériau et de conducteurs mixtes comme deuxième ou troisième matériaux est particulièrement avantageuse pour obtenir des débits élevés. On utilisera de préférence le générateur pour produire de l'oxygène à injecter dans un courant de méthane.
Patent CA-2289953-A1 (CA)
Title: Methods for producing retroviral vectors with an altered tropism
Inventor: BERKHOUT BENJAMIN
IPC: C07K14/16
Filed: 1998-05-12
Abstract: The invention relates to the field of molecular biology and virology. It particularly relates to the field of genetic engineering techniques and the use of these techniques in preparing novel pharmaceuticals, in particular in the field of gene therapy and to methods for producing novel retroviral vectors, these vectors and recombinant viruses obtainable by the methods. The invention provides a method for producing a retrovirus or a recombinant virus derived therefrom having an altered tropism, whereby the genome of the virus is modified so that at least one of its translation initiation sites is at least partially functionally inhibited. The invention also provides a method for producing a recombinant vector encoding a recombinant retrovirus having modified tropism, comprising culturing said retrovirus in a host cell to allow for the virus to circumvent an introduced inhibition, identifying the sequence which was mutated to circumvent said inhibition and introducing the mutation in another vector based on a retrovirus or provirus of a retrovirus.
Patent CA-2291232-A1 (CA)
Title: Water containing wax-based product
Inventor: TAN MANUEL L
IPC: A61K8/37
Filed: 1998-05-27
Abstract: The present invention relates to a wax-based composition comprising at least about 0.5-30 % water in a water-in-oil emulsion, wherein water is encapsulated in a lamellar lipid vesicle capable of withstanding wax melting point temperatures. The composition is useful in delivering water soluble actives in an anhydrous base, and is particularly well-adapted for uses in lipsticks and lip-care products.
Patent CA-2292733-A1 (CA)
Title: Polymeric supported catalysts for olefin polymerization
Inventor: WALZER JOHN FLEXER JR
IPC: C08F4/02
Filed: 1998-06-05
Abstract: The described invention provides a low fouling, high particle density polymerization process and an olefin polymerization catalyst composition comprising the reaction product of a) a polymeric support i) having a surface area of from about 1 to 400 m2/g and ii) functionalized with an acidic protoncontaining ammonium salt of a non-coordinating anion, and b) an organometallic transition metal compound having ancillary ligands, at least one labile ligand capable of abstraction by protonation by said ammonium salt and at least one labile ligand into which an olefinic monomer can insert for polymerization. In a preferred embodiment, the polymeric support has a surface area of 10 m2/g and is particularly suitable for use with high activity organometallic, transition metal catalyst compounds.
Patent CA-2293853-A1 (CA)
Inventor: MATHEWS EUGENE P
IPC: H04M3/00
Filed: 2000-01-04
Abstract: A call center is configured to include a capability for generating measures of occupancy for one or more agents. At least one value characterizing an occupancy measure determination for a given agent is stored in a memory associated with the call center, and used in generating an occupancy measure for that agent. In an illustrative embodiment, a set of stored values for the given agent includes an initial occupancy value for the agent, expressed in terms of a percentage. The occupancy measure for the agent may then be set to the initial occupancy value upon a log-in by the agent, so as to avoid undue oscillation in the occupancy measure after log-in. The set of stored values for the given agent may also include, for example, a limit which specifies a maximum amount of time for a designated activity which is to be considered as occupied time in generating the occupancy measure, or a limit which specifies a maximum effect of a designated activity in generating the occupancy measure. The designated activity may be, for example, after call work or auxiliary work performed by the agent.